HomeCompareESBS vs MRK

ESBS vs MRK: Dividend Comparison 2026

ESBS yields 29.85% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESBS wins by $73.5K in total portfolio value
10 years
ESBS
ESBS
● Live price
29.85%
Share price
$6.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.2K
Annual income
$17,289.99
Full ESBS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — ESBS vs MRK

📍 ESBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESBSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESBS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESBS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESBS
Annual income on $10K today (after 15% tax)
$2,537.31/yr
After 10yr DRIP, annual income (after tax)
$14,696.49/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, ESBS beats the other by $6,099.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESBS + MRK for your $10,000?

ESBS: 50%MRK: 50%
100% MRK50/50100% ESBS
Portfolio after 10yr
$94.5K
Annual income
$13,701.88/yr
Blended yield
14.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ESBS
No analyst data
Altman Z
0.2
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESBS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESBSMRK
Forward yield29.85%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$131.2K$57.7K
Annual income after 10y$17,289.99$10,113.78
Total dividends collected$89.4K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESBS vs MRK ($10,000, DRIP)

YearESBS PortfolioESBS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,685$2,985.07$11,213$373.04+$2.5KESBS
2$18,461$3,817.85$12,667$512.06+$5.8KESBS
3$24,566$4,813.27$14,439$708.14+$10.1KESBS
4$32,272$5,986.12$16,640$988.16+$15.6KESBS
5$41,881$7,349.34$19,432$1,394.07+$22.4KESBS
6$53,726$8,913.51$23,057$1,992.90+$30.7KESBS
7$68,173$10,686.48$27,889$2,894.79+$40.3KESBS
8$85,618$12,673.05$34,518$4,286.29+$51.1KESBS
9$106,486$14,874.79$43,912$6,494.35+$62.6KESBS
10$131,230$17,289.99$57,714$10,113.78+$73.5KESBS

ESBS vs MRK: Complete Analysis 2026

ESBSStock

ES Bancshares, Inc., through its subsidiary, Empire State Bank, provides various commercial banking products and services in New York. The company offers various deposit products, including personal and business checking and money market accounts, personal and business savings accounts, individual retirement accounts, and certificates of deposits. It also provides SBA loans and lines of credit, commercial term loans, commercial letters of credit, and commercial real estate loans, as well as mortgage loans secured by one-to four-family residences. In addition, the company offers debit card, direct deposit, automatic loan payment and transfer, combined statement, remote deposit, cash and escrow management, wire transfer, night depository, and online and telephone banking services. ES Bancshares, Inc. was founded in 2004 and is based in Newburgh, New York.

Full ESBS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ESBS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESBS vs SCHDESBS vs JEPIESBS vs OESBS vs KOESBS vs MAINESBS vs JNJESBS vs ABBVESBS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.